Deforestation, Air Pollution and Brazilian COVID-19 Variant
Journal Title: Journal of Clinical Immunology & Microbiology - Year 2021, Vol 2, Issue 1
Abstract
Aim of this work is to submit to the researcher the relationship whit climate condition, air pollution and deforestation in Manaus zone in Brazil and the rapid spread of so called Brazilian COVID-19 variant. Also other situation are analysed like South Africa variant. This topics of research make possible to better study the phenomena of new COVID-19 variant explosion and related effect on increase velocity in spread and in increased mortality rate in some region of the world. The ability of this variant to elude immune system need to seek also in environmental toxicology some response.
Authors and Affiliations
Luisetto M*, Naseer Almukthar, Khaled Edbey, Fiazza C, Ahmed Yesvi Rafa, Ghulam Rasool, Latishev O Yurevich
Keywords
Related Articles
- EP ID EP699089
- DOI http://dx.doi.org/10.46889/JCIM.2021.2103
- Views 68
- Downloads 0
Methicillin-Resistant Staphylococcus Aureus (MRSA): Prevalence and Antimicrobial Sensitivity Pattern among Outdoor and Indoor Patients Dhaka City Hospital, Bangladesh
Methicillin-Resistant Staphylococcus Aureus (MRSA) is one of the significant pathogens with associated public-health concern in the world. This present study has been focused on the prevalence of MRSA and their antibio...
Deforestation, Air Pollution and Brazilian COVID-19 Variant
Aim of this work is to submit to the researcher the relationship whit climate condition, air pollution and deforestation in Manaus zone in Brazil and the rapid spread of so called Brazilian COVID-19 variant. Also othe...
Antibiotic Profile of Biofilm Producing Coagulase Negative Staphylococci Isolated from Various Clinical Specimens
Introduction: CoNS which are normal commensal of skin and mucous membranes of human, when presented with an opportunity, are known to cause infections. The most common species among the group are the S. epidermidis. Prod...
Analysis of the Level of IgG to SARS-CoV-2 Virus and Molecular Markers of Activation of CD25, CD54 (ICAM-1) and CD95 Lymphocytes in the Patients Who were Not Ill with COVID-19, Recovered from COVID-19 and Who had Acute Respiratory Infections. The Results of the Correction of Impaired Immune Homeostasis Using the Multitarget Immunotherapy Drug Mercureid
Currently, the researchers have come across a paradox which consists in detecting protective IgG antibodies to SARS-CoV-2 virus only in a subset of patients who have recovered from COVID-19. The other patients, who were...
Repurposing Donepezil to Treat COVID-19: A Call for Retrospective Analysis of Existing Patient Datasets
We hypothesize that patients treated with donepezil will show decreased risk of death following COVID-19 infection. The acetylcholinesterase antagonist donepezil is widely prescribed for early-stage Alzheimer’s disease...